Scrianen Folic acid

The core variety of Scrianen Pharmaceutical "Scrianen Folic acid tablet", is the scientific research results obtained after 13 years of cooperation between the Chinese and American governments, costing 20 million US dollars and 250,000 medical observations. The results have been adopted by more than 50 countries in the world. And has been published in the Lancet, the New England Journal of Medicine, the Chinese Medical Journal, the Chinese Journal of Epidemiology and other famous academic journals at home and abroad. As early as 1997, "Scrianen  folic acid tablet" obtained the new drug certificate and production approval issued by the National Ministry of Health, becoming the world's first listed 0.4mg folic acid tablet, its quality standards have been set by the World Health Organization as an international standard, and has been collected by the Chinese pharmacopoeia. "Syan folic acid tablets" as the national Ministry of Health "ten years of 100 scientific and technological achievements" key projects to promote the country, and by the Ministry of Science and Technology, the Ministry of Commerce and other five ministries as "national key new products."

At present, low-dose folic acid has been widely used in various clinical disciplines, which has been widely studied and highly recognized by experts in various disciplines at home and abroad. Numerous studies at home and abroad have confirmed that taking low-dose folic acid every day can effectively reduce the level of homocysteine in the body and become an effective intervention measure to prevent and improve chronic cardiovascular and cerebrovascular diseases. It has been recommended in authoritative guidelines and consensus such as "Chinese Guidelines for the Prevention and Treatment of Hypertension", "Guidelines for the Rational Use of Hypertension", "Chinese Guidelines for the Primary Prevention of Stroke", "Chinese Guidelines for the Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack" and "Chinese Multidisciplinary Expert Consensus on Clinical Rational supplementation of folic acid".